Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Erasca, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 154
- +10 vs. Q4 2024
- Shares held
- 224.3M
- −5.15M (−2.2%) vs. Q4 2024
- Total value
- $307.3M
- −$268.6M (−46.6%) vs. Q4 2024
- New holders
- 28
- 48 more added
- Sold out
- 18
- 47 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ERAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $5.13B |
| Q1 2026 | 225 | $4.39B |
| Q4 2025 | 154 | $815.7M |
| Q3 2025 | 141 | $468.5M |
| Q2 2025 | 142 | $277.1M |
| Q1 2025 | 154 | $307.3M |
| Q4 2024 | 146 | $579.5M |
| Q3 2024 | 132 | $633.4M |
| Q2 2024 | 126 | $480.6M |
| Q1 2024 | 108 | $149.7M |
| Q4 2023 | 119 | $147.5M |
| Q3 2023 | 109 | $140.4M |
| Q2 2023 | 112 | $205.2M |
| Q1 2023 | 118 | $234.9M |
| Q4 2022 | 107 | $343.9M |
| Q3 2022 | 88 | $627.9M |
| Q2 2022 | 89 | $428.3M |
| Q1 2022 | 82 | $626.6M |
| Q4 2021 | 63 | $988.0M |
| Q3 2021 | 55 | $919.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Erasca, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rhumbline Advisers | 209,443 | $286.9K | 0.00% | −14,445−6.5% | Reduced |
| Alps Advisors Inc | 210,283 | $288.1K | 0.00% | −18,336−8.0% | Reduced |
| Walleye Capital LLC | 215,220 | $294.9K | 0.00% | +76,512+55.2% | Added |
| Susquehanna International Group, LLP | 236,950 | $324.6K | 0.00% | +121,449+105.1% | Added |
| Gsa Capital Partners LLP | 238,705 | $327.0K | 0.03% | +238,705 | New |
| IPG Investment Advisors LLC | 248,108 | $339.9K | 0.08% | +78,130+46.0% | Added |
| Barclays PLC | 249,594 | $341.9K | 0.00% | −128,170−33.9% | Reduced |
| TD Asset Management Inc | 256,032 | $350.8K | 0.00% | +15,286+6.3% | Added |
| Swiss National Bank | 328,700 | $450.3K | 0.00% | −32,500−9.0% | Reduced |
| DAFNA Capital Management LLC | 340,000 | $465.8K | 0.13% | +340,000 | New |
| Two Sigma Advisers, LP | 343,100 | $470.0K | 0.00% | −251,500−42.3% | Reduced |
| FMR LLC | 359,378 | $492.3K | 0.00% | +39,020+12.2% | Added |
| AQR Capital Management LLC | 396,202 | $542.8K | 0.00% | +339,177+594.8% | Added |
| UBS Asset Management Americas Inc | 445,580 | $610.4K | 0.00% | +811+0.2% | Added |
| Nuveen, LLC | 483,583 | $662.5K | 0.00% | +483,583 | New |
| Bank of New York Mellon Corp | 548,269 | $751.1K | 0.00% | +3,450+0.6% | Added |
| Morgan Stanley | 578,238 | $792.2K | 0.00% | −176,500−23.4% | Reduced |
| Two Sigma Investments, LP | 591,637 | $810.5K | 0.00% | −366,608−38.3% | Reduced |
| Atom Investors LP | 810,455 | $1.11M | 0.14% | +35,038+4.5% | Added |
| Wellington Management Group LLP | 850,147 | $1.16M | 0.00% | +384,475+82.6% | Added |
| Prosight Management, LP | 947,110 | $1.30M | 0.43% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 956,507 | $1.31M | 0.00% | −176,493−15.6% | Reduced |
| Tang Capital Management LLC | 1,190,012 | $1.63M | 0.09% | +587,097+97.4% | Added |
| Sio Capital Management, LLC | 1,356,186 | $1.86M | 0.56% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,415,244 | $1.94M | 0.00% | −59,341−4.0% | Reduced |
| Charles Schwab Investment Management Inc | 1,441,656 | $1.98M | 0.00% | −321,040−18.2% | Reduced |
| Northern Trust Corp | 1,665,809 | $2.28M | 0.00% | −51,300−3.0% | Reduced |
| Dimensional Fund Advisors LP | 1,838,128 | $2.52M | 0.00% | −273,858−13.0% | Reduced |
| Sofinnova Investments, Inc. | 1,877,085 | $2.57M | 0.19% | +81,205+4.5% | Added |
| Goldman Sachs Group Inc | 1,936,257 | $2.65M | 0.00% | −865,373−30.9% | Reduced |
| Bank of America Corp | 1,948,825 | $2.67M | 0.00% | +3,052+0.2% | Added |
| Marshall Wace, LLP | 2,027,027 | $2.78M | 0.00% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 2,162,162 | $2.96M | 0.23% | 00.0% | Unchanged |
| AH Capital Management, L.L.C. | 2,862,500 | $3.92M | 0.56% | 00.0% | Unchanged |
| Millennium Management LLC | 3,224,518 | $4.42M | 0.00% | −953,382−22.8% | Reduced |
| Affinity Asset Advisors, LLC | 3,341,519 | $4.58M | 0.72% | +842,088+33.7% | Added |
| PFM Health Sciences, LP | 3,489,559 | $4.78M | 0.37% | −900,868−20.5% | Reduced |
| Woodline Partners LP | 4,147,433 | $5.68M | 0.04% | +1580.0% | Added |
| State Street Corp | 4,177,885 | $5.72M | 0.00% | −2,431,596−36.8% | Reduced |
| Geode Capital Management, LLC | 4,757,852 | $6.52M | 0.00% | +188,033+4.1% | Added |
| Octagon Capital Advisors LP | 5,136,795 | $7.04M | 1.53% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 5,405,404 | $7.41M | 2.80% | 00.0% | Unchanged |
| Vivo Capital, LLC | 6,756,756 | $9.26M | 1.23% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 7,367,996 | $10.1M | 2.11% | −175,905−2.3% | Reduced |
| Siren, L.L.C. | 8,757,249 | $12.0M | 0.68% | −99,930−1.1% | Reduced |
| Paradigm Biocapital Advisors LP | 10,802,354 | $14.8M | 0.68% | +50,000+0.5% | Added |
| ARCH Venture Management, LLC | 11,055,554 | $15.1M | 7.34% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 12,315,004 | $16.9M | 0.68% | 00.0% | Unchanged |
| Vanguard Group Inc | 12,727,425 | $17.4M | 0.00% | +53,525+0.4% | Added |
| Logos Global Management LP | 13,000,000 | $17.8M | 3.17% | +500,000+4.0% | Added |
| BlackRock, Inc. | 15,598,808 | $21.4M | 0.00% | −162,556−1.0% | Reduced |
| VR Adviser, LLC | 16,216,216 | $22.2M | 1.89% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 17,292,164 | $23.7M | 0.02% | +581,817+3.5% | Added |
| Frazier Life Sciences Management, L.P. | 22,575,851 | $30.9M | 1.41% | +3,184,164+16.4% | Added |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −209,751−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −200,300−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −156,973−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −72,493−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −42,632−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −27,031−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,664−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −16,158−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −14,838−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −10,681−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −2,861−100.0% | Sold out |
| Clear Street LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −510−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −424−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −333−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| EDBI Pte Ltd | – | – | – | – | Not filed |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |